Autolus Therapeutics plc financial data

Symbol
AUTL on Nasdaq
Location
London, United Kingdom
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 849% % -40%
Quick Ratio 25% %
Debt-to-equity 106% % 44%
Return On Equity -64% % -0.17%
Return On Assets -31% % 15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 266,143,286 shares 0.01%
Entity Public Float $613,667,644 USD 120%
Weighted Average Number of Shares Outstanding, Basic 266,141,431 shares 0.02%
Weighted Average Number of Shares Outstanding, Diluted 266,141,431 shares 0.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $8,982,000 USD -11%
Revenue from Contract with Customer, Excluding Assessed Tax $21,194,000 USD
Research and Development Expense $112,886,000 USD -22%
General and Administrative Expense $83,138,000 USD 116%
Operating Income (Loss) $273,942,000 USD -25%
Nonoperating Income (Expense) $53,757,000 USD 51%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $220,185,000 USD 19%
Income Tax Expense (Benefit) $4,617,000 USD 11161%
Net Income (Loss) Attributable to Parent $224,802,000 USD 17%
Earnings Per Share, Basic 0 USD/shares 32%
Earnings Per Share, Diluted 0 USD/shares 32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $86,124,000 USD -87%
Accounts Receivable, after Allowance for Credit Loss, Current $15,000 USD -86%
Inventory, Net $27,723,000 USD
Other Assets, Current $0 USD
Assets, Current $514,577,000 USD -28%
Deferred Income Tax Assets, Net $2,389,000 USD -30%
Property, Plant and Equipment, Net $66,851,000 USD 51%
Operating Lease, Right-of-Use Asset $56,625,000 USD -6.4%
Assets $661,947,000 USD -20%
Accounts Payable, Current $10,967,000 USD 673%
Employee-related Liabilities, Current $22,611,000 USD 46%
Accrued Liabilities, Current $52,264,000 USD 10%
Contract with Customer, Liability, Current $4,800,000 USD
Liabilities, Current $83,071,000 USD 58%
Contract with Customer, Liability, Noncurrent $253,437,000 USD 11%
Operating Lease, Liability, Noncurrent $61,007,000 USD 25%
Other Liabilities, Noncurrent $472,000 USD 5.6%
Liabilities $396,495,000 USD 13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,920,000 USD -448%
Retained Earnings (Accumulated Deficit) $1,296,420,000 USD -21%
Stockholders' Equity Attributable to Parent $265,452,000 USD -44%
Liabilities and Equity $661,947,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $75,565,000 USD -87%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $59,547,000 USD -11072%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $131,554,000 USD -125%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87,622,000 USD -87%
Deferred Tax Assets, Valuation Allowance $156,997,000 USD 28%
Deferred Tax Assets, Gross $160,236,000 USD 27%
Operating Lease, Liability $65,835,000 USD 26%
Depreciation $8,200,000 USD 11%
Payments to Acquire Property, Plant, and Equipment $8,243,000 USD 1447%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $228,824,000 USD 3.6%
Lessee, Operating Lease, Liability, to be Paid $118,709,000 USD 8.4%
Operating Lease, Liability, Current $4,828,000 USD 35%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,961,000 USD 5.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,854,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $52,874,000 USD -7.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,193,000 USD -8.1%
Deferred Tax Assets, Operating Loss Carryforwards $136,406,000 USD 30%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,161,000 USD -24%
Operating Lease, Payments $1,725,000 USD 33%
Additional Paid in Capital $1,566,662,000 USD 1.1%
Amortization of Intangible Assets $1,247,000 USD
Depreciation, Depletion and Amortization $1,992,000 USD 10%
Share-based Payment Arrangement, Expense $17,228,000 USD 38%
Interest Expense $17,001,000 USD -124%